glp-1 receptor agonist PDB-101: Molecule of the Month: Agonists GLP-1 Receptor Agonists and Other
Description
GLP-1 receptor agonists, like Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for diabetes management, show promising potential in treating psoriasis and psoriatic arthritis (PsA)

doi: 10.1093/asj/sjae132

It helps regulate blood sugar, digestion, and appetite

Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment

One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients

This low dose is not intended to trigger immediate weight loss but to help your body adjust to the medication and minimize the likelihood of common gastrointestinal side effects like nausea and vomiting
